MA37533B1 - Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans - Google Patents
Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitansInfo
- Publication number
- MA37533B1 MA37533B1 MA37533A MA37533A MA37533B1 MA 37533 B1 MA37533 B1 MA 37533B1 MA 37533 A MA37533 A MA 37533A MA 37533 A MA37533 A MA 37533A MA 37533 B1 MA37533 B1 MA 37533B1
- Authority
- MA
- Morocco
- Prior art keywords
- oregano
- essential oil
- antibacterial effect
- actinomycetemcomitans
- aaggregatibacter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Abstract
L’application de |'effet antibactérien de l'huile essentielle d’origan (origanum compactum) d’origine marocaine sur une souche bactérienne orale virulente; aggregatibacter actinomycetemcomitans clone jp2. Cette souche originelle n’a jamais fait l’objet de tests antimicrobiens à base d’huiles essentielles. Cette nouvelle application englobe aussi bien la méthodologie que les résultats obtenus. La technique utilisée est une méthode simple, claire, basée sur la preuve et offrant une meilleure précision et une meilleure reproductibilité des résultats.The application of the antibacterial effect of the essential oil of oregano (origanum compactum) of Moroccan origin on a virulent oral bacterial strain; aggregatibacter actinomycetemcomitans clone jp2. This original strain has never been the subject of antimicrobial tests based on essential oils. This new application encompasses both the methodology and the results obtained. The technique used is a simple, clear, evidence-based method with improved accuracy and reproducibility of results.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MA37533A MA37533B1 (en) | 2014-11-13 | 2014-11-13 | Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans |
PCT/MA2014/000037 WO2016076686A1 (en) | 2014-11-13 | 2014-11-27 | Pharmacological composition of oregano (essential oil) exhibiting an antibacterial effect on the jp2 clone of aggregatibacter actinomycetemcomitans |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MA37533A MA37533B1 (en) | 2014-11-13 | 2014-11-13 | Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37533A1 MA37533A1 (en) | 2016-06-30 |
MA37533B1 true MA37533B1 (en) | 2017-01-31 |
Family
ID=52574401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37533A MA37533B1 (en) | 2014-11-13 | 2014-11-13 | Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans |
Country Status (2)
Country | Link |
---|---|
MA (1) | MA37533B1 (en) |
WO (1) | WO2016076686A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8119169B2 (en) * | 2004-12-28 | 2012-02-21 | Colgate-Palmolive Company | Oregano oral care compositions and methods of use thereof |
EP2663582B1 (en) * | 2011-01-13 | 2018-07-11 | Austin Research Labs Corp. | High load dispersions for treating infections |
-
2014
- 2014-11-13 MA MA37533A patent/MA37533B1/en unknown
- 2014-11-27 WO PCT/MA2014/000037 patent/WO2016076686A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
MA37533A1 (en) | 2016-06-30 |
WO2016076686A1 (en) | 2016-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020001048A1 (en) | Monoclonal antibodies against bcma. (divisional request 201800281) | |
MA46109A (en) | HIGH CONCENTRATE, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS | |
NZ725569A (en) | Lubricant formulations | |
CL2020001391A1 (en) | Lyophilized formulation of a monoclonal antibody against transthyretin. | |
CO2022017690A2 (en) | Antibodies against sars-cov-2 and methods of selection and use thereof | |
AR108546A1 (en) | COMPOSITIONS, KITS AND METHODS FOR WEED CONTROL | |
CY1124338T1 (en) | 3-PHOSPHOGLYCERATE DEHYDROGENATION INHIBITORS AND THEIR USES | |
AR111099A1 (en) | USE OF A SERUM FOR CLOTHING WASHING | |
BR102019017062A8 (en) | TOPICAL COMPOSITIONS INCLUDING PICHIA ANOMALA AND RETINOL | |
MX2021006977A (en) | Anellosomes and methods of use. | |
MA37533B1 (en) | Pharmacological composition of oregano (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans | |
MA37532A1 (en) | Pharmacological composition of palmarosa (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans | |
MA37530A1 (en) | Pharmacological composition of citronella (essential oil) with antibacterial effect on aggregatibacter actinomycetemcomitans | |
MA37534A1 (en) | Pharmacological composition of thyme (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans | |
MA37529A1 (en) | Pharmacological composition of pennyroyal mint (essential oil) with antibacterial effect on the aggregatibacter actinomycetemcomitans. | |
MA37531A1 (en) | Pharmacological composition of the bitter orange (essential oil) with antibacterial effect on aaggregatibacter actinomycetemcomitans | |
BR102019017344A8 (en) | TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE | |
BR112017018618A2 (en) | osmanthus odorant | |
FR3097125B1 (en) | Coloring composition comprising a combination of two plant extracts of Lawsonia inermis | |
AR112996A1 (en) | ANTIBODY-DRUG CONJUGATE EVALUATION METHODS | |
CL2018002949A1 (en) | Compositions for oral care. | |
MA49960A (en) | HIGH CONCENTRATED, LOW VISCOSITY MASP-2 INHIBITOR ANTIBODY FORMULATIONS, KITS AND METHODS OF TREATMENT OF SUBJECTS WITH ATYPICAL HEMOLYTIC SYNDROME | |
AU2015205151A1 (en) | 5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method | |
CL2018000568A1 (en) | Feed composition for the prevention and treatment of parasitic fish infection | |
EA201990561A1 (en) | COMPOSITIONS CONTAINING ACID EXTRACTS OF MASTIC GUM, AND THEIR APPLICATION FOR TREATMENT OF OPTICAL NEUROPATHY |